Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 05/16/2025 | PUT | $7.50 | 2,041 | +53 | +2.67% |
| 06/20/2025 | CALL | $10.00 | 10 | +1 | +11.11% |
| 05/16/2025 | CALL | $2.50 | 0 | 0 | |
| 05/16/2025 | CALL | $7.50 | 1,640 | 0 | |
| 05/16/2025 | CALL | $10.00 | 1,771 | 0 | |
| 05/16/2025 | CALL | $12.50 | 19 | 0 | |
| 01/15/2027 | PUT | $5.00 | 6 | 0 | |
| 01/15/2027 | PUT | $7.50 | 2 | 0 | |
| 01/15/2027 | PUT | $10.00 | 0 | 0 | |
| 01/15/2027 | PUT | $12.50 | 64 | 0 | |
| 01/15/2027 | PUT | $15.00 | 0 | 0 | |
| 05/16/2025 | CALL | $5.00 | 50 | -3 | -5.66% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Fidelity Growth Company Fund | 3.14% | 1.87M | 89.43M |
| Vanguard Total Stock Market Index Fund | 2.60% | 1.55M | 74.07M |
| Vanguard Specialized-Health Care Fund | 2.36% | 1.41M | 67.13M |
| SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 2.33% | 1.39M | 66.39M |
| Vanguard Small-Cap Index Fund | 2.18% | 1.3M | 62.18M |
| iShares Russell 2000 ETF | 1.91% | 1.14M | 54.53M |
| Fidelity Select Portfolios - Biotechnology | 1.66% | 989.75k | 47.24M |
| Hartford Mid Cap Fund | 1.38% | 821.38k | 39.2M |
| Vanguard Small-Cap Growth Index Fund | 1.26% | 753.84k | 35.98M |
| Fidelity Series Growth Company Fund | 1.20% | 715.81k | 34.17M |
Comprehensive Market Analysis of Latest Published Different Types of Depression Reports | DelveInsight
02/25 02:00 pm
GlobeNewswire Inc.
Read moreDeal Dispatch: Sage And Silvus Are Up For Sale, MrBeast Secures $20B For TikTok
01/31 03:20 pm
Benzinga
Read moreKuehn Law Encourages Investors of Sage Therapeutics, Inc. to Contact Law Firm
01/24 02:38 pm
GlobeNewswire Inc.
Read moreBiogen Bid For Sage Therapeutics Could Strengthen Neurology Strategy: Analysts
01/13 03:06 pm
Benzinga
Read moreSage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE
10/28 10:10 am
Benzinga
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
10/24 08:02 pm
Benzinga
Read moreSage Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. October 28, 2024 Deadline to file Lead Plaintiff Motion
10/23 08:06 pm
GlobeNewswire Inc.
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
10/22 11:05 pm
Benzinga
Read moreSAGE DEADLINE NOTICE: Rosen, A HIGHLY RECOGNIZED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action – SAGE
10/22 07:35 pm
GlobeNewswire Inc.
Read moreSage Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. October 28, 2024 Deadline to file Lead Plaintiff Motion
10/21 04:43 pm
GlobeNewswire Inc.
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
10/21 05:49 am
Benzinga
Read moreSAGE DEADLINE: RLF, A TOP-RANKED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important October 28 Deadline in Securities Class Action – SAGE
10/19 09:45 pm
GlobeNewswire Inc.
Read moreROSEN, A TOP-RANKED LAW FIRM, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action – SAGE
10/17 08:42 pm
GlobeNewswire Inc.
Read moreROSEN, A LEADING LAW FIRM, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
10/11 09:07 pm
GlobeNewswire Inc.
Read moreGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)
10/09 12:00 pm
GlobeNewswire Inc.
Read moreROSEN, LEADING INVESTOR COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
10/03 06:44 pm
GlobeNewswire Inc.
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
09/30 08:45 am
Benzinga
Read moreROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
09/29 09:08 pm
GlobeNewswire Inc.
Read moreGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)
09/27 02:33 pm
GlobeNewswire Inc.
Read moreROSEN, LEADING TRIAL ATTORNEYS, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
09/26 07:26 pm
GlobeNewswire Inc.
Read moreBiogen Terminates Collaboration With Sage Therapeutics For Neurological Disorder Candidate
09/26 10:38 am
Benzinga
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
09/25 08:30 am
Benzinga
Read moreGlancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)
09/20 12:49 pm
GlobeNewswire Inc.
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
09/18 08:15 am
Benzinga
Read moreDeadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Sage Therapeutics, Inc. (SAGE)
09/17 06:37 pm
Benzinga
Read moreSAGE THERAPEUTICS, INC. (NASDAQ: SAGE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Sage Therapeutics, Inc. Investors of Upcoming Deadline
09/16 02:59 pm
GlobeNewswire Inc.
Read moreROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
09/14 09:36 am
GlobeNewswire Inc.
Read moreGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc. (SAGE) Investors
09/13 03:14 pm
Benzinga
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
09/13 08:30 am
Benzinga
Read moreINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc. (SAGE) Investors
09/12 01:15 pm
Benzinga
Read moreThe Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Sage Therapeutics, Inc. (SAGE) Investors
09/12 12:07 pm
Benzinga
Read moreINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Sage Therapeutics, Inc. (SAGE) on Behalf of Investors
09/11 07:55 pm
Benzinga
Read moreROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
09/10 02:53 pm
GlobeNewswire Inc.
Read moreThe Law Offices of Frank R. Cruz Announces Investigation of Sage Therapeutics, Inc. (SAGE) on Behalf of Investors
09/10 12:04 pm
Benzinga
Read moreSAGE THERAPEUTICS, INC. (NASDAQ: SAGE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Sage Therapeutics, Inc. Investors of Upcoming Deadline
09/09 04:59 pm
GlobeNewswire Inc.
Read moreSAGE INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
09/07 10:07 am
GlobeNewswire Inc.
Read moreONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics
09/06 09:55 am
GlobeNewswire Inc.
Read moreSAGE INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
09/01 10:11 am
GlobeNewswire Inc.
Read moreROSEN, NATIONAL TRIAL COUNSEL, Encourages Sage Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SAGE
09/01 08:32 am
GlobeNewswire Inc.
Read moreSAGE THERAPEUTICS, INC. (NASDAQ: SAGE) INVESTOR ALERT: Investors With Large Losses in Sage Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
08/30 01:45 am
GlobeNewswire Inc.
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
08/29 06:13 pm
Benzinga
Read moreSAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
08/29 03:01 pm
Benzinga
Read moreSAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Sage Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead the Sage Therapeutics Class Action Lawsuit
08/29 02:33 pm
GlobeNewswire Inc.
Read moreGlobal Maternal Mental Health Market to Exhibit Growth at Tremendous CAGR of ~15% by 2030 | DelveInsight
08/14 01:00 pm
GlobeNewswire Inc.
Read moreBiogen (BIIB) Q2 Earnings & Sales Beat, 2024 Guidance Raised
08/01 12:25 pm
Zacks Investment Research
Read more